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Abstract
Surgery elicits broad alterations in haemodynamic, endocrine-meta-
bolic and immune responses. The inflammatory response is essential for
structural and functional repair of injured tissue, as complement, granulo-
cytes, macrophages and many other mediators are required for appropriate
wound healing. Injury, surgical or traumatical is connected with the acute
disorder of immunological system which is manifesting as increased incli-
nation to infections. The inflammatory response is an important determi-
nant of outcome after major surgery. Perioperative excessive stimulation of
the inflammatory and haemostatic systems plays a role in the development
of postoperative ileus, ischaemia-reperfusion syndromes (e.g. myocardial
infarction), hypercoagulation syndromes (e.g. deep venous thrombosis) and
pain; together, these represent a significant fraction of major postoperative
disorders. Regional anaestehsia administered local anaesthetics prevent or
modulate many of these processes.
In the center of interests there are the serum-levels of Th1 i Th2 cytokines
before and after regional and general anaesthesia and in such a way would
like to confirm through the immunological status that the spinal anaesthe-
sia is significantly more favourable for the patient.
INTRODUCTION
Survival depends on the immune system’s ability to defend the bodyagainst attack from invading pathogens and injury. However, the
extent of such a response is of critical importance; deficient responses
may result in secondary infections from immunosuppression and ex-
cessive responses can be more harmful than the original insult (1, 2).
Cytokine synthesis and release is an essential component of the innate
immune system, but inappropriate, excessive production results in a
generalized systemic inflammatory response which damages distant
organs.
Cytokines
Cytokines are lowmolecular- weight proteins which after binding to
specific receptors affect immune cell differentiation, proliferation, and
activity. They are not stored, but are newly synthesized and released
during activation of the inflammatory cascade. They are multi-func-
tional but in essence direct the inflammatory response to sites of infec-
tion and injury and enhance wound healing. Pro-inflammatory cyto-
kines include tumour necrosis factor-a (TNF-a), interleukin-1 (IL-1),
IL-6, and IL-8. Anti-inflammatory cytokines include IL-1 receptor an-
tagonist, IL-10, IL-13, and TNF-binding proteins 1 and 2. (3, 4, 5, 6, 7).
Tumour necrosis factor (TNF) is a primary and potent mediator of in-
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Overview
cells and has a half-life within the circulation of 20 min.
TNF is also a potent inducer of other pro-inflammatory
cytokines and activating mediators distally in the cyto-
kine cascade. TNF-a elicits considerable metabolic and
haemodynamic changes and is capable of causing end-
-organ dysfunction. Other functions include activation
of coagulation, muscle catabolism, and cachexia (3, 6–11,
49). There are two forms of IL-1 (IL-a and IL-b) which
recognize the same cell surface receptors and therefore
share various biological activities. IL-1 is synthesized by
monocytes and leucocytes and other cell types and has a
halflife of 6 min. Both IL-a and IL-b evoke metabolic
and haemodynamic changes similar to those of TNF-a,
activate production of other cytokines, and attenuate
pain perception by promoting the release of b-endo-
rphins (3, 6, 7, 8).
Effects of pro-inflammatory cytokines is a sensitive
balance between pro- and anti-inflammatory cytokines.
Pro-inflammatory cytokines operate close to their site of
release, but if the inflammatory response escapes local
control, it elicits a generalized systemic response. TNF-a
and IL-1 have short half-lives and system of membrane
reservoirs hold the cytokines close to the site of release
and the anti-inflammatory cytokines modify the host in-
flammatory response(7) (Table 1).
1. TNF-a can produce immediate and delayed negative
inotropic effects on myocardial tissue and has been
shown to cause left ventricular dysfunction. (9.10)
TNF-a, IL-1b, and IL-6 have also been implicated in
causing myocardial depression by direct actions on
the myocytes (4, 11).
2. Pro-inflammatory cytokines have significant effects
on vascular tone, mainly mediated through the NO
pathway, with resultant vasodilatation. TNF-a and
IL-1b have both been observed to increase NO pro-
duction, and failure to respond to vasoconstrictors af-
ter prolonged exposure to these cytokines has been re-
ported (4).
3. Inflammatory lung injury occurs when activated neu-
trophils and macrophages migrate from the pulmo-
nary vasculature into the alveolar and interstitial spa-
ces. Macrophages secrete TNF-a, IL-1, and IL-8 which
in turn stimulate further cytokine production by lung
epithelial and mesenchymal cells (4, 12). IL-8 has
been shown to have a pathogenic role in the establish-
ment of acute respiratory.
4. In animal studies, TNF-a has been shown to induce
glomerular injury in kidneys without pre-existing re-
nal disease. In response to TNF-a and IL-1, glomeru-
lar cells produce oxygen free radicals, complement,
arachidonic acid derivatives, and NO which further
escalates local inflammation with resultant additional
glomerular and tubular cell damage (4).
5. Predominantly IL-6, but also TNF-a and IL-1b stim-
ulate the liver to alter its synthetic function and in-
crease the synthesis of acute phase proteins such as se-
rum amyloid A, a2-macroglobulins, and C-reactive
protein (CRP). The substrates for this increase in pro-
duction are provided by cytokine-mediated skeletal
muscle breakdown, hence the alternative name for
TNF-a; cachectin (4).
6. Cytokines are not directly involved in the coagulation
pathways, but TNF-a and IL-1 have been shown to
modulate the extrinsic pathway of coagulation and
the protein C pathway. Evidence suggests important
roles for these cytokines in disseminated intravascular
coagulation (DIC) and thrombosis (13–27). IL-1 has
also been shown to inhibit fibrinolysis (14).
7. The consequences of ageing on the immune system
are thought to contribute considerably to morbidity
and mortality in the elderly (15). TNF-a and IL-6
concentrations are raised in the elderly and studies
have shown that, in response to surgical trauma, the
elderly have a magnified and late inflammatory cyto-
kine response (16).
Conditions of cytokine excess
Inappropriate synthesis of cytokines occurs with ex-
cessive or persistent activation of macrophages and neu-
trophils. If this escapes local control, cytokines enter the
systemic circulation resulting in widespread activation of
inflammatory cascades and the systemic inflammatory
response syndrome (SIRS). This evokes further release
of inflammatory cytokines resulting in a downward spi-
ral of organ dysfunction and ultimately multiple organ
dysfunction syndrome (MODS). In patients with ARDS
alone, mortality is around 50% and with each additional
organ failing, this risk increases in a multiplicative fash-
ion. TNF-a, IL-1b, IL-6, and IL-8 have been strongly
implicated as mediators of sepsis and studies of sepsis
have shown elevated circulating levels of these cytokines
(3, 4, 18, 19). Furthermore, raised levels of pro-inflam-
matory cytokines generally appear to correlate with se-
verity of illness and outcome (3, 4, 19, 20) with IL-6 most
closely associated with mortality (11, 16). Increased pla-
sma concentrations of proinflammatory cytokines have
been demonstrated after major surgery (7, 21, 22) and
the magnitude of the cytokine-mediated inflammatory
response appears to be related to the extent of the surgical
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TABLE 1
Effects of pro-inflammatory cytokines on organ systems.
Cardiac Negative inotropic effect on myocardium
Left ventricular dysfunction
Vascular Vasodilatation
Respiratory Acute lung injury
Pathogenic role in ARDS
Renal Glomerular injury
Tubular cell damage
Hepatic Increased synthesis of acute phase proteins
Coagulation Modulation of extrinsic and Protein C path-
ways
Inhibition of fibrinolysis
Role in development of DIC and thrombosis
insult (68). High plasma concentrations of IL-6 in re-
sponse to major surgery appear to be associated with
postoperative mortality (7). After severe trauma, serum
levels of TNF-a, IL-6, and IL-8 are significantly elevated
and there appears to be a close relationship between the
extent of pro-inflammatory cytokine release and the se-
verity of injury and hospital mortality (23, 24, 25). Hae-
morrhage results in a markedly increased production of
pro-inflammatory cytokines in the lungs and is associ-
ated with the onset of ARDS with TNF-a playing a cen-
tral role in the pathogenesis of acute lung injury after
haemorrhage, even after adequate resuscitation (26–32).
Anti-inflammatory mechanisms
Anti-inflammatory cytokines such as IL-10, TNF-
-binding protein, IL-receptor antagonist (IL-1ra), and
transforming growth factor-b (TGF-b), which are pro-
duced through a normal immune response, can inhibit
the release of TNF-a and other pro-inflammatory cyto-
kines (33, 1–20, 76). TNF-binding protein interferes with
the binding of TNF to its receptor and thus inhibiting its
actions (46). 'Stress' hormones such as glucocorticoids,
epinephrine, norepinephrine, and a-melanocyte-stimu-
lating hormone inhibit cytokine production. Conditions
of cytokine excess are systemic inflamatory response sin-
drom (SIRS)can be classified as resulting from either in-
fectious or non-infectious conditions, surgery, trauma,
haemorhagic shock, pankreatitis, burns, ischaemia-re-
perfusion injury.
Neural regulation of the immune
response
Cytokines and the immunomodulatory function of
the vagus nerve been shown to up-regulate IL-10 pro-
duction thereby enhancing the anti-inflammatory action
(34). Other local effectors such as prostaglandin E2,
acute phase proteins, heat-shock proteins, spermine, and
feutin all have additional roles in limiting the immune
response. Impairment or loss of any of these endogenous
anti-inflammatory pathways can turn a normally self-
-limiting response into an excessive and potentially dam-
aging one 1.
Immune system also functions as a sensory organ.
This information would then be relayed to the central
nervous system (CNS) to bring about a favourable physi-
ological response (35). Recent research has revealed an
autonomic neural pathway termed 'the inflammatory re-
flex', which has both immunosensing and immunosup-
pressing functions. Compared with the humoral anti-in-
flammatory mechanisms which are slow, diffuse, and
dependent on concentration gradients, the inflammatory
reflex pathway is fast, localized, and integrated (1, 36).
Pharmacological agents
Despite recent advances in intensive care treatment,
MODS resulting from excessive and prolonged pro-in-
flammatory cytokine release in conditions such as sepsis,
ischaemia/ reperfusion, and haemorrhagic shock remains
associated with a high mortality rate. Pro-inflammatory
cytokines such as TNF-a and IL-1b have been identified
as 'early' mediators of the inflammatory response and
when neutralized using specific antibodies can prevent
the development of septic shock in animal models(76,
84). The studies have shown that TNF-a antibodies are
ineffective for critically ill patients (4, 37) if treatment is
commenced after serum TNF-a has been cleared.
Excessive inflammatory stimulation may lead to host
auto-injury inflammatory syndromes (e.g. SIRS and
ARDS), sepsis, multi-system organ failure (MSOF) and
eventually death. In a much greater proportion of the
surgical patient population, postoperative pain and post-
operative hypercoagulation represent significant mor-
bidity due to excess activation of inflammatory respon-
ses. Since these responses are initiated during surgery,
intraoperative interventions might decrease their frequency
and severity.
Immunological system in human beings is adaptable
system, able to recognize and eliminate manifold strange
cells and molecules. The role of immunoreaction is de-
fence against infections, defence against tumor and main-
tenance of gene and antigene homeostasis(1z).Injury,
whether surgical or traumatic, is connected with acute
disorder of immunological system which is manifested as
increased inclination to infections. This phenomenon is
primarily characterized by disorder of cell immunity and
function of macrophages. In serious infections and big
extensive injuries there is present reduced production of
Th1 cytokine and increased production of Th2 cytokine,
which is connected with immunosuppresion (2)
General anaesthesia
Applied medicines may also affect the immunological
status (3). General anaesthesia with opioides cause de-
pression of immunological system. Influence of non-
-opioide anaesthetics on immunological system is not
explained to such an extent (4). Propofol has antiinflam-
matory properties, decreasing production of proinflam-
matory cytokines, thus inhibiting neutrofile function (7,
8). Inhalation anaesthetics in mechanical ventilation sti-
mulate inflammatory response on transcription level wi-
thin 2 hours (Volatile anaesthetics augment expression of
proinflammatory cytokines in rat alveolar macrophages
during mechanical ventilation.
Regional anaesthesia
Administration of local anaesthetics was designed to
provide intraoperative anaesthesia and postoperative an-
algesia. However, in recent years it has become clear that
regional administered local anaesthetics have benefits far
beyond anaesthesia and pain relief; indeed, the tech-
nique has significant impact on the outcome of major
surgical procedures. A recently published meta-analysis
concluded that neuraxial anaesthesia using local anaes-
thetics decreased overall mortality by approximately one
third, reduced the odds of deep vein thrombosis by 44%,
pulmonary embolism by 55%, transfusion requirements
by 50%, pneumonia by 39%, and respiratory depression
Period biol, Vol 113, No 2, 2011. 153
Anaestethic technique and cytokine response Katarina [aki} et al.
by 59%. There were also reductions in myocardial infarc-
tion and renal failure (26). In addition, epidural anaes-
thesia using local anaesthetics has been shown to attenu-
ate the endocrine and metabolic response to upper ab-
dominal surgery, to reduce postoperative ileus, and to
shorten duration of intubation and intensive care stay in
patients undergoing abdominal aortic operations.
Local anaesthetics modulate the inflammatory re-
sponse in vivo (27). They prevent or reduce inflamma-
tory disorders, such as reperfusion injury in heart (28,
29, 38). Beneficial effects of local anaesthetic treatment
in inflammatory bowel diseases are well documented
(39, 40). In contrast to corticosteroids, which depress
the inflammatory response and impact negatively on
postoperative outcome, local anaesthetics selectively in-
hibit only overactive responses of the inflammatory and
haemostatic systems without affecting normal function
(41, 42). Local anaesthetics decrease inflammation with-
out increasing the susceptibility to infections, and pre-
vent postoperative thrombotic events without increas-
ing bleeding.
The study was demonstrated that intravenous lidocai-
ne effectively prevents postoperative thrombotic events,
without increasing bleeding (3, 10, 47). Similar effects to
those obtained after epidural administration of local an-
aesthetics, and can potentially be explained by an antiin-
flammatory effect of local anaesthetics. That the effects
are likely due to systemic absorption, and not to neura-
xial block, is suggested by findings that epidural anaes-
thesia using local anaesthetic (leading to neuraxial blo-
ckade plus significant plasma local anaesthetic concentra-
tions) prevents surgery-induced hypercoagulation (41),
whereas spinal anaesthesia (leading to neuraxial block-
ade but no significant plasma local anaesthetic levels)
does not affect coagulation.
Local anaesthetics reduce postoperative ileus and du-
ration of hospital stay (35).
Recent findings demonstrate a neuroprotective effect
after intravenous administration of local anaesthetics,
leading to significant reduction in cognitive dysfunction
after surgery (4).
Mechanisms of action of local
anaesthetics
The cellular substrate for these actions is likely to re-
side, in part, in the fact that priming, but not activation,
that neutrophils is inhibited by local anaesthetics (44,
23). Priming refers to a process whereby the response of
neutrophils to a subsequent activating stimulus is poten-
tiated. Release of oxygen metabolites is markedly en-
hanced when neutrophils have previously been primed.
The priming process has been shown to be a critical com-
ponent of neutrophil-mediated tissue injury both in vitro
and in vivo (5), and inhibition of this process by local an-
aesthetics would be expected to reduce such injury. The
mechanisms underlying these actions of local anaesthet-
ics on priming have not been elucidated in detail, but se-
lective inhibition of Gq protein function by local anaes-
thetics has been demonstrated recently (45). Since Gq
protein is important for many inflammatory and hae-
mostatic signalling pathways, the effects of local anaes-
thetics might be explained at least in part by functional
inhibition of Gq protein. The antithrombotic actions of
local anaesthetics might result in part from inhibition of
Gq protein function in platelets. There is strong evi-
dence for an inflammatory modulating action of local
anaesthetic, and it is reasonable to hypothesise that this
effect explains why continuous intravenous administra-
tion of these compounds in the perioperative period has
several beneficial effects, similar to those obtained with
epidural administration. However, the underlying mo-
lecular and cellular mechanisms of those actions are not
applying them to manage the inflammatory response
during surgery, could open possibilities for a new, effec-
tive therapeutic approach to prevention of postoperative
disorders.
Regional anaesthesia-analgesia attenuates periopera-
tive immunosuppression. The hypothesis that patients
who receive combined propofol/paravertebral anaesthe-
sia-analgesia (propofol /paravertebral) exhibited reduced
levels of protumorigenic cytokines and matrix metallo-
proteinases (MMPs) and elevated levels of antitumo-
rigenic cytokines compared with patients receiving sevo-
flurane anaesthesia with opioid analgesia (sevoflurane/
opioid). Regional anaesthesia-analgesia for cancer sur-
gery alters a minority of cytokines influential in regulat-
ing perioperative cancer immunity (50).
However, any reduction of immunosupression is less
expressed in regional – spinal anaesthesia. Local anaes-
thetics lidokain and bupivacain have influence on a re-
lease of IL-1 beta from human lymphocytes in vitro re-
ducing chemotaxial and fagocite activity of neutrofiles
and inhibits motogen-induced proliferation of lympho-
cytes (51, 52, 53, 54, 55). However, the influence of levo-
bupivacain that we shall apply to a spinal area, on T lym-
phocytes and production of cytokine has not yet been
explored (56, 57, 58).
CONCLUSION
General or regional anaesthesia alone, without opera-
tion, has periodical and minimum effects to immunolog-
ical system. It is established that various anaesthesiolo-
gical procedures in the same operation cause various
trend of alteration of cytokine level in serum. Spinal an-
aesthesia results in less immunosupression, i.e. main-
tains the number of Th1 cells, thus stimulating the cell
immunity. Serious disorder of immunological system may
cause complications as there are disorders in wound
healing, increased number of infections, non-adequate
response to the stress, multiorganic suppression and in-
creased incidency of metastases.
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